Latest Capital Efficiency News

Page 3 of 40
Little Green Pharma has entered a $7.8 million sale and leaseback agreement for its Western Australia production site, aiming to fuel growth in Australia and Europe while maintaining operational control.
Ada Torres
Ada Torres
19 Feb 2026
MoneyMe Limited reported a 17.2% rise in gross revenue and a 43.7% reduction in net loss for the half-year to December 2025, underpinned by strong loan book growth and enhanced funding capacity.
Claire Turing
Claire Turing
19 Feb 2026
Solvar Limited reported a 5.8% rise in half-year NPAT to $20 million, driven by the sale of its New Zealand written-off loan book and expanded debt facilities. The company also announced a special dividend and outlined growth plans in commercial lending.
Claire Turing
Claire Turing
18 Feb 2026
Dexus has reported a strong half-year result with a $348.5 million profit turnaround, robust leasing growth, and strategic capital moves including a $950 million equity raise and a 10% on-market buyback.
Eva Park
Eva Park
18 Feb 2026
Mirvac Group reported a robust half-year result with a 5% rise in operating profit and a significant boost in residential sales, underpinned by a $1 billion joint venture with Mitsubishi Estate. The company’s strategic pipeline restocking and strong leasing performance signal promising growth ahead.
Eva Park
Eva Park
18 Feb 2026
Horizon Minerals unveils robust scoping study results for its Black Swan Project in WA, outlining a low-capital, high-return gold development targeting 102,000 ounces annually. The company launches a $175 million placement to fund construction and advance operations toward mid-2027 commissioning.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Viva Leisure has announced a year-long on-market share buy-back program targeting up to 10% of its issued shares, aiming to capitalise on market volatility and reinforce its strong cash flow outlook.
Victor Sage
Victor Sage
17 Feb 2026
Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.
Ada Torres
Ada Torres
17 Feb 2026
Judo Capital Holdings has delivered a robust 1H26 result, posting a 26% half-on-half profit before tax increase and upgrading its net interest margin guidance for the second half. The bank’s SME lending franchise continues to expand rapidly, supported by strong deposit growth and a solid capital position.
Claire Turing
Claire Turing
17 Feb 2026
Swift TV Ltd has secured two four-year reseller contracts to deliver its children’s entertainment content at Sydney Children’s Hospital Randwick and Westmead, marking a strategic move into the hospital sector.
Sophie Babbage
Sophie Babbage
17 Feb 2026
Challenger Limited reported a solid first half of FY26 with a 2% rise in normalised net profit after tax and record annuity sales. The company also announced a $150 million on-market share buy-back, reflecting confidence in its strong capital position.
Claire Turing
Claire Turing
17 Feb 2026
North Stawell Minerals is broadening its gold exploration strategy beyond Victoria, aiming to capitalise on strong gold prices with a diversified Australian project pipeline.
Maxwell Dee
Maxwell Dee
16 Feb 2026